International Journal of Clinical Medicine

Vol.4 No.1(2013), Paper ID 27353, 6 pages

DOI:10.4236/ijcm.2013.41011

 

Successful Treatment of Life-Threatening Cerebral Bleeding Associated with Disseminated Intravascular Coagulation Using Recombinant Human Soluble Thrombomodulin in a Patient with Mixed Phenotype Acute Leukemia with t (9; 22) (q34; q11.2); Bcr-Abl1

 

Naoki Takezako, Takashi Ishii, Akihisa Nagata, Naohiro Sekiguchi, Satoshi Noto, Akiyoshi Miwa

 

Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo, Japan
Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo, Japan
Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo, Japan
Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo, Japan
Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Tokyo, Japan
Department of Hematol- ogy, National Center for Global Health and Medicine, Tokyo, Japan

 

Copyright © 2013 Naoki Takezako, Takashi Ishii, Akihisa Nagata, Naohiro Sekiguchi, Satoshi Noto, Akiyoshi Miwa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


N. Takezako, T. Ishii, A. Nagata, N. Sekiguchi, S. Noto and A. Miwa, "Successful Treatment of Life-Threatening Cerebral Bleeding Associated with Disseminated Intravascular Coagulation Using Recombinant Human Soluble Thrombomodulin in a Patient with Mixed Phenotype Acute Leukemia with t (9; 22) (q34; q11.2); Bcr-Abl1," International Journal of Clinical Medicine, Vol. 4 No. 1, 2013, pp. 52-57. doi: 10.4236/ijcm.2013.41011.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.